These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8181470)

  • 1. Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy.
    Siligardi G; Samorí B; Melandri S; Visconti M; Drake AF
    Eur J Biochem; 1994 May; 221(3):1117-25. PubMed ID: 8181470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis of elcatonin in solution.
    Ogawa K; Nishimura S; Doi M; Kyogoku Y; Hayashi M; Kobayashi Y
    Eur J Biochem; 1994 Jun; 222(2):659-66. PubMed ID: 8020504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants.
    Arvinte T; Drake AF
    J Biol Chem; 1993 Mar; 268(9):6408-14. PubMed ID: 8454613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding analysis of hormonal polypeptide calcitonins and the oxidized calcitonins using electrospray ionization mass spectrometry combined with H/D exchange.
    Nabuchi Y; Asoh Y; Takayama M
    J Am Soc Mass Spectrom; 2004 Nov; 15(11):1556-64. PubMed ID: 15519222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation analysis of eel calcitonin--comparison with the conformation of elcatonin.
    Ogawa K; Nishimura S; Uchiyama S; Kobayashi K; Kyogoku Y; Hayashi M; Kobayashi Y
    Eur J Biochem; 1998 Oct; 257(2):331-6. PubMed ID: 9826177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
    Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
    J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
    McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M
    Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution.
    Amodeo P; Motta A; Strazzullo G; Castiglione Morelli MA
    J Biomol NMR; 1999 Feb; 13(2):161-74. PubMed ID: 10070757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating calcitonin fibrillogenesis: an antiparallel alpha-helical dimer inhibits fibrillation of salmon calcitonin.
    Andreotti G; Motta A
    J Biol Chem; 2004 Feb; 279(8):6364-70. PubMed ID: 14594801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues.
    Kapurniotu A; Taylor JW
    J Med Chem; 1995 Mar; 38(5):836-47. PubMed ID: 7877149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues.
    Kapurniotu A; Kayed R; Taylor JW; Voelter W
    Eur J Biochem; 1999 Oct; 265(2):606-18. PubMed ID: 10504392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of salmon calcitonin.
    Meyer JP; Pelton JT; Hoflack J; Saudek V
    Biopolymers; 1991 Feb; 31(2):233-41. PubMed ID: 2043752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable human calcitonin analogues with high potency on bone together with reduced anorectic and renal actions.
    Uda K; Kobayashi Y; Hisada T; Orlowski RC; Bastian JW; Arnaud CD; Wakabayashi K
    Biol Pharm Bull; 1999 Mar; 22(3):244-52. PubMed ID: 10220278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into interactions between the alpha-helical region of the salmon calcitonin antagonists and the human calcitonin receptor using photoaffinity labeling.
    Pham V; Dong M; Wade JD; Miller LJ; Morton CJ; Ng HL; Parker MW; Sexton PM
    J Biol Chem; 2005 Aug; 280(31):28610-22. PubMed ID: 15929987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation of the alpha form of human calcitonin gene-related peptide (CGRP) in aqueous solution as determined by circular dichroism spectroscopy.
    Manning MC
    Biochem Biophys Res Commun; 1989 Apr; 160(1):388-92. PubMed ID: 2785388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation states of gramicidin A along the pathway to the formation of channels in model membranes determined by 2D NMR and circular dichroism spectroscopy.
    Abdul-Manan N; Hinton JF
    Biochemistry; 1994 Jun; 33(22):6773-83. PubMed ID: 7515684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homooligopeptides composed of hydrophobic amino acid residues interact in a specific manner by taking alpha-helix or beta-structure toward lipid bilayers.
    Lee S; Yoshitomi H; Morikawa M; Ando S; Takiguchi H; Inoue T; Sugihara G
    Biopolymers; 1995 Sep; 36(3):391-8. PubMed ID: 7669922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformation of human calcitonin gene-related peptide (8-37) in aqueous solution as determined by circular dichroism spectroscopy.
    Matsuura J; Manning MC
    J Pharm Biomed Anal; 1993 Feb; 11(2):89-93. PubMed ID: 8504192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids.
    Epand RM; Epand RF; Orlowski RC; Schlueter RJ; Boni LT; Hui SW
    Biochemistry; 1983 Oct; 22(22):5074-84. PubMed ID: 6652057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.